- Issuer ticker
-
TLSI
- Reported as of
-
11 Mar 2026
- Net transaction value
-
-$13,171
- SEC form
-
4
- Accepted by SEC
-
20 Mar 2026, 16:25:55 UTC
Filing notes and source
Key filing fact
Jodi Devlin filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 20 Mar 2026.
Key facts
- This page summarizes Jodi Devlin's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2026, 16:25.
Change
- Previous filing in this sequence was filed on 25 Nov 2025.
- Current net transaction value: -$13,171.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001992151
Primary reporting owner
Devlin Jodi
- Relationship
-
Chief of Clinical Operations
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Sale
- Transaction value
- -$4,799
- Shares
- -1,162
- Change %
- -1.2%
- Price
-
$4.13
- Shares after
- 99,409
- Date
- 11 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
TLSI
transaction
Common Stock
Sale
- Transaction value
- -$7,247
- Shares
- -1,772
- Change %
- -1.8%
- Price
-
$4.09
- Shares after
- 97,637
- Date
- 12 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
TLSI
transaction
Common Stock
Sale
- Transaction value
- -$1,125
- Shares
- -273
- Change %
- -0.28%
- Price
-
$4.12
- Shares after
- 97,364
- Date
- 16 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote